Cardiovascular outcomes and rates of fractures and falls among patients with brand-name versus generic L-thyroxine use-Reference-Cited by-同舟云学术

Cardiovascular outcomes and rates of fractures and falls among patients with brand-name versus generic L-thyroxine use

Published:2021-06-05 Issue:3 Volume:74 Page:592-602
ISSN:1355-008X
Container-title:Endocrine
language:en
Short-container-title:Endocrine

Author:

Brito Juan P.^ORCID,Ross Joseph S.^ORCID,Deng Yihong,Sangaralingham Lindsey,Graham David J.,Qiang Yandong,Wang Zhong,Yao Xiaoxi^ORCID,Zhao Liang,Smallridge Robert C.,Bernet Victor,Shah Nilay D.^ORCID,Lipska Kasia J.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://link.springer.com/content/pdf/10.1007/s12020-021-02779-x.pdf

Reference17 articles.

1. R. Rodriguez-Gutierrez, S. Maraka, N.S. Ospina, V.M. Montori, J.P. Brito, Levothyroxine overuse: time for an about face? Lancet Diab. Endocrinol. (2017). https://doi.org/10.1016/S2213-8587(16)30276-5

2. E.D. Kantor, C.D. Rehm, J.S. Haas, A.T. Chan, E.L. Giovannucci, Trends in prescription drug use among adults in the United States from 1999-2012. Jama (2015). https://doi.org/10.1001/jama.2015.13766

3. M. Viswanathan, C.E. Golin, C.D. Jones et al. Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Ann. Intern. Med. (2012). https://doi.org/10.7326/0003-4819-157-11-201212040-00538

4. J.S. Ross, S. Rohde, L. Sangaralingham et al. Generic and brand-name thyroid hormone drug use among commercially insured and medicare beneficiaries, 2007 Through 2016. J. Clin. Endocrinol. Metab. (2019). https://doi.org/10.1210/jc.2018-02197

5. N. Huo, L. Chen, A.U. Mishuk et al. Generic levothyroxine initiation and substitution among Medicare and Medicaid populations: a new user cohort study. Endocrine (2020). https://doi.org/10.1007/s12020-020-02211-w

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Schilddrüsenerkrankungen;Arzneiverordnungs-Report 2023;2023

2. Optimal Thyroid Hormone Replacement;Endocrine Reviews;2021-09-20